Friday, 16 October 2026European Markets
ExploreSearch
ViaNews EU
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 2, 2026

Mizuho resets view on Snowflake stock after CRO change

View original at finance.yahoo.com
Mizuho resets view on Snowflake stock after CRO change Snowflake (SNOW) stock is starting to look interesting again. Shares are down about 30% this year while the company has just appointed a new chief revenue officer as it tries to reaccelerate growth and improve sales execution…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • A leadership change introduces near-term risks to pipeline continuity, deal timing, and expansion motion, just as the company tries to turn product momentum into usage growth

    60% confidence

  • Mizuho sees over 40% upside for Snowflake stock with $220 price target

    60% confidence

  • JB has been a key driver of our success for the past ten years, and has consistently proven his ability to deliver results at scale

    60% confidence

  • The next question is whether Q1 results show stable pipeline trends and continued customer expansion under the new CRO

    60% confidence

  • JB has been a key driver of Snowflake's success for the past ten years and has consistently proven his ability to deliver results at scale

    60% confidence

  • Leadership change introduces near-term risks to pipeline continuity, deal timing, and expansion motion, just as the company tries to turn product momentum into usage growth

    60% confidence

  • Mizuho sees over 40% upside for Snowflake stock with $220 price target

    60% confidence

  • Product revenue growth in the second half of FY2026 coming in lighter than expected

    60% confidence

Data points we hold from this source

Snowflake Inc. · analyst target price239 USD
Snowflake Inc. · enterprise value50 USD
Snowflake Inc. · forward pe ratio84.3 ratio
Snowflake Inc. · implied upside55 percent
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com
Mizuho resets view on Snowflake stock after CRO change — Source | Via News | ViaNews EU